AKT1 and nasopharyngeal carcinoma: In the tumour microenvironment of human nasopharyngeal carcinoma, IL‐17A mediates AKT1 acetylation via p300, activating the Akt signalling pathway and stimulating the proliferation of nasopharyngeal carcinoma cells.53